ABO blood group predictions are brand new, and still under development. We're rolling it out to you so we can see how it performs on real data. All conclusions are still greatly limited by the general lack of phased data, the lack of genotyping at all of the necessary snps, and other factors.
best guess:rs8176719(I;D) rs8176746(C;C)rs8176719(I;D) indicates you have one type-O allele
Blood, you see, doesn't just come in types A, B, AB, and O. The "positive" or "negative?" Nope. In fact, let's get all the way into the weeds: Scientists have since discovered over 300 proteins that contribute to blood type. The AB+ on your blood donor card? Yeah, that's a massive oversimplification... read more at Beyond Blood Type: Genomics Can Show What You're Really Made Of
or
It would be straightforward if we all had the same blood. But we don't. On the surface of every one of our red blood cells, we have up to 342 antigens - molecules capable of triggering the production of specialised proteins called antibodies. It is the presence or absence of particular antigens that determines someone's blood type.
Some 160 of the 342 blood group antigens are 'high-prevalence', which means that they are found on the red blood cells of most people. If you lack an antigen that 99 per cent of people in the world are positive for, then your blood is considered rare. If you lack one that 99.99 per cent of people are positive for, then you have very rare blood.
If a particular high-prevalence antigen is missing from your red blood cells, then you are 'negative' for that blood group. If you receive blood from a 'positive' donor, then your own antibodies may react with the incompatible donor blood cells, triggering a further response from the immune system. These transfusion reactions can be lethal. Read more at The man with the golden blood.
Index | Gene | SNP | Geno | Repute | Magnitude | Summary |
---|---|---|---|---|---|---|
1 | rs7466519 | not tested | ||||
2 | rs8176750 | not tested | ||||
3 | rs56202119 | not tested | ||||
4 | i4000505 | not tested | ||||
5 | rs56231718 | not tested | ||||
6 | rs55788852 | not tested | ||||
7 | rs55927860 | not tested | ||||
8 | rs8176749 | not tested | ||||
9 | rs56190619 | not tested | ||||
10 | rs55783488 | not tested | ||||
11 | rs56355240 | not tested | ||||
12 | i4000504 | not tested | ||||
13 | rs56409303 | not tested | ||||
14 | rs55805279 | not tested | ||||
15 | rs56106480 | not tested | ||||
16 | rs8176747 | not tested | ||||
17 | rs41302905 | not tested | ||||
18 | rs8176746 | (C;C) | 0 | |||
19 | rs8176745 | not tested | ||||
20 | rs55951833 | not tested | ||||
21 | rs8176743 | not tested | ||||
22 | i5007173 | not tested | ||||
23 | rs55739900 | not tested | ||||
24 | rs56116432 | not tested | ||||
25 | rs56031507 | not tested | ||||
26 | rs8176741 | not tested | ||||
27 | rs56408700 | not tested | ||||
28 | rs8176740 | (A;T) | ||||
29 | rs55827808 | not tested | ||||
30 | rs8176739 | not tested | ||||
31 | rs56223957 | not tested | ||||
32 | rs56189011 | not tested | ||||
33 | rs56089890 | not tested | ||||
34 | rs55727303 | not tested | ||||
35 | rs7853989 | not tested | ||||
36 | rs55964869 | not tested | ||||
37 | rs55756402 | not tested | ||||
38 | i5007171 | not tested | ||||
39 | rs1053878 | not tested | ||||
40 | rs55658842 | not tested | ||||
41 | rs7873522 | not tested | ||||
42 | rs8176732 | not tested | ||||
43 | rs2073824 | not tested | ||||
44 | rs8176722 | (G;G) | ||||
45 | rs8176721 | not tested | ||||
46 | rs8176720 | not tested | ||||
47 | rs8176719 | (I;D) | most likely to be of blood type A or B | |||
48 | rs56231711 | not tested | ||||
49 | rs8176717 | not tested | ||||
50 | rs512770 | not tested | ||||
51 | rs641959 | not tested | ||||
52 | rs514708 | not tested | ||||
53 | rs55958637 | not tested | ||||
54 | rs549446 | not tested | ||||
55 | rs8176704 | (C;C) | ||||
56 | rs574347 | not tested | ||||
57 | rs688976 | not tested | ||||
58 | rs687289 | (C;T) | ||||
59 | rs2073828 | not tested | ||||
60 | rs55876802 | not tested | ||||
61 | rs8176694 | not tested | ||||
62 | rs672316 | not tested | ||||
63 | rs657152 | (G;T) | ||||
64 | rs8176682 | not tested | ||||
65 | rs474279 | not tested | ||||
66 | rs500498 | not tested | ||||
67 | rs505922 | (C;T) | Bad | 1.2x risk of pancreatic cancer | ||
68 | rs507666 | (A;G) | ||||
69 | rs630014 | (C;T) |
Index | Gene | SNP | Geno | Repute | Magnitude | Summary |
---|---|---|---|---|---|---|
1 | rs1053878 | not tested | ||||
2 | rs2073824 | not tested | ||||
3 | rs2073828 | not tested | ||||
4 | rs2519093 | not tested | ||||
5 | rs41302905 | not tested | ||||
6 | rs500498 | not tested | ||||
7 | rs505922 | (C;T) | Bad | 1.2x risk of pancreatic cancer | ||
8 | rs507666 | (A;G) | ||||
9 | rs512770 | not tested | ||||
10 | rs514659 | (A;C) | ||||
11 | rs55722397 | not tested | ||||
12 | rs55964869 | not tested | ||||
13 | rs56392308 | not tested | ||||
14 | rs574347 | not tested | ||||
15 | rs612169 | not tested | ||||
16 | rs630014 | (C;T) | ||||
17 | rs643434 | not tested | ||||
18 | rs644234 | not tested | ||||
19 | rs657152 | (G;T) | ||||
20 | rs687289 | (C;T) | ||||
21 | rs687621 | not tested | ||||
22 | rs7853989 | not tested | ||||
23 | rs8176694 | not tested | ||||
24 | rs8176704 | (C;C) | ||||
25 | rs8176719 | (I;D) | most likely to be of blood type A or B | |||
26 | rs8176720 | not tested | ||||
27 | rs8176722 | (G;G) | ||||
28 | rs8176740 | (A;T) | ||||
29 | rs8176741 | not tested | ||||
30 | rs8176743 | not tested | ||||
31 | rs8176746 | (C;C) | 0 | |||
32 | rs8176747 | not tested | ||||
33 | rs8176749 | not tested | ||||
34 | rs8176750 | not tested |
Index | Gene | SNP | Geno | Repute | Magnitude | Summary |
---|---|---|---|---|---|---|
1 | rs2231142 | (A;C) | Bad | 2.1 | 1.74x increased gout risk; gefinitib takers 4x more susceptible to diarrhea | |
2 | rs72552713 | (G;G) | Good | 0 | common in complete genomics | |
3 | rs1800497 | (C;C) | Good | 3 | Normal (A2/A2) | |
4 | rs429358 | (T;T) | Good | 0 | common | |
5 | rs7412 | (C;C) | Bad | 1.1 | more likely to gain weight if taking olanzapine | |
6 | rs4680 | (A;G) | Intermediate dopamine levels, other effects | |||
7 | rs12720461 | (C;C) | Good | 0 | normal | |
8 | rs2069514 | not tested | ||||
9 | rs35694136 | not tested | ||||
10 | rs56107638 | not tested | ||||
11 | rs762551 | (A;C) | 2.1 | Carrier of one CYP1A2*1F allele; Slow Caffeine Metabolizer. | ||
12 | rs12721655 | not tested | ||||
13 | rs2279343 | (A;G) | ||||
14 | rs28399499 | (T;T) | Good | 0 | common in complete genomics | |
15 | rs3211371 | not tested | ||||
16 | rs34097093 | (C;C) | Good | 0 | common in complete genomics | |
17 | rs34223104 | (T;T) | Good | 0 | common in complete genomics | |
18 | rs35303484 | not tested | ||||
19 | rs3745274 | not tested | ||||
20 | rs12248560 | (C;C) | Good | 0 | normal | |
21 | rs17878459 | not tested | ||||
22 | rs17884712 | not tested | ||||
23 | rs17885098 | not tested | ||||
24 | rs17886522 | not tested | ||||
25 | rs28399504 | (A;A) | Good | 0 | normal | |
26 | rs3758580 | not tested | ||||
27 | rs41291556 | (T;T) | Good | 0 | normal | |
28 | rs4244285 | (G;G) | Good | 0 | normal | |
29 | rs4986893 | (G;G) | Good | 0 | normal | |
30 | rs55640102 | not tested | ||||
31 | rs56337013 | (C;C) | Good | 0 | normal | |
32 | rs6413438 | (C;C) | Good | 0 | normal | |
33 | rs72552267 | (G;G) | Good | 0 | normal | |
34 | rs72558186 | not tested | ||||
35 | rs1057910 | (A;A) | Good | 0.1 | normal; no effect on warfarin metabolism | |
36 | rs1799853 | (C;C) | Good | 1 | normal; no risk of altered warfarin metabolism or NSAID metabolism | |
37 | rs28371685 | (C;C) | Good | 0 | normal | |
38 | rs28371686 | not tested | ||||
39 | rs56165452 | not tested | ||||
40 | rs72558187 | not tested | ||||
41 | rs72558188 | not tested | ||||
42 | rs72558190 | not tested | ||||
43 | rs7900194 | not tested | ||||
44 | rs7900194 | not tested | ||||
45 | rs9332130 | (A;A) | Good | 0 | normal | |
46 | rs9332131 | (I;I) | normal | |||
47 | rs9332239 | (C;C) | Good | 0 | normal | |
48 | rs1065852 | not tested | ||||
49 | rs1080985 | not tested | ||||
50 | rs147960066 | not tested | ||||
51 | rs16947 | not tested | ||||
52 | rs28371706 | not tested | ||||
53 | rs28371720 | not tested | ||||
54 | rs28371725 | (G;G) | Good | 0 | normal | |
55 | rs35742686 | not tested | ||||
56 | rs3892097 | not tested | ||||
57 | rs5030655 | (I;I) | normal | |||
58 | rs5030862 | (G;G) | Good | 0 | normal | |
59 | rs5030863 | not tested | ||||
60 | rs5030865 | not tested | ||||
61 | rs5030865 | not tested | ||||
62 | rs5030867 | (A;A) | Good | 0 | normal | |
63 | rs59421388 | (C;C) | Good | 0 | common in complete genomics | |
64 | rs72549349 | not tested | ||||
65 | rs72549351 | not tested | ||||
66 | rs72549353 | not tested | ||||
67 | rs72549354 | not tested | ||||
68 | rs72549357 | not tested | ||||
69 | rs769258 | not tested | ||||
70 | rs12721629 | not tested | ||||
71 | rs2740574 | (A;A) | Good | 0 | normal | |
72 | rs35599367 | (C;C) | Good | 0 | common in complete genomics | |
73 | rs4646438 | not tested | ||||
74 | rs4986910 | (T;T) | Good | 0 | normal | |
75 | rs4987161 | (T;T) | Good | 0 | normal | |
76 | rs55785340 | (A;A) | Good | 0 | normal | |
77 | rs10264272 | (C;C) | Good | 0 | normal | |
78 | rs15524 | not tested | ||||
79 | rs28365083 | (C;C) | Good | 0 | normal | |
80 | rs28383468 | (C;C) | Good | 0 | normal | |
81 | rs28383479 | (G;G) | Good | 0 | normal | |
82 | rs41279854 | (A;A) | Good | 0 | normal | |
83 | rs41303343 | not tested | ||||
84 | rs55817950 | (G;G) | Good | 0 | normal | |
85 | rs55965422 | not tested | ||||
86 | rs776746 | (G;G) | Bad | 2.5 | CYP3A5*3 homozygote; CYP3A5 non-expressor | |
87 | rs1799963 | not tested | ||||
88 | rs6025 | (G;G) | Good | 0 | normal/common risk of thrombosis | |
89 | rs1801131 | (A;C) | Bad | 2.1 | Possibly impaired folate metabolism | |
90 | rs1801133 | (C;T) | Bad | 2.2 | 1 copy of C677T allele of MTHFR = 65% efficiency in processing folic acid | |
91 | rs1799971 | (A;G) | Bad | 2.5 | stronger cravings for alcohol. if alcoholic, naltrexone treatment 2x more successful | |
92 | rs2306283 | (C;C) | ||||
93 | rs4149056 | (C;T) | Bad | 2.1 | reduced breakdown of some drugs; 5x increased myopathy risk for statin users | |
94 | rs55737008 | not tested | ||||
95 | rs56061388 | (T;T) | ||||
96 | rs56101265 | not tested | ||||
97 | rs59502379 | not tested | ||||
98 | rs72559745 | not tested | ||||
99 | rs1902023 | not tested | ||||
100 | rs8050894 | not tested | ||||
101 | rs9923231 | (T;T) | 2.1 | reduced warfarin dose if treated for VTE | ||
102 | rs9934438 | (A;A) | Bad | 2.5 | coumadin resistance |